Norfloxacin + TinidazoleThird Party Manufacturing in India

Norfloxacin + Tinidazole works via dual pathways, combining DNA gyrase inhibition with nitro-reduced intermediate-mediated microbial DNA strand breakage. It inhibits both bacterial replication and anaerobic protozoal survival to help the body eliminate mixed gastrointestinal infections. Unlike single-agent alternative classes, it targets both bacterial pathogens and amoebic parasites responsible for severe diarrheal syndromic profiles. It is highly effective and well-tolerated for rapid gastrointestinal relief. The manufacturing framework coordinates materials linked to CAS 70458-96-7 to ensure high dose stability.

We supply professional contract options for Norfloxacin + Tinidazole third party manufacturing in India, presenting an established commercial product designed for high-incidence markets.

Therapeutic Uses

• Amoebic Dysentery: Resolves severe bloody diarrhea caused by mixed protozoal and bacterial pathogens.
• Infectious Diarrhea: Treats intense gastrointestinal cramps and loose stools triggered by foodborne organisms.

Why Manufacturers Choose Norfloxacin + Tinidazole

This fixed-dose combination remains a first-line clinical selection for acute infectious diarrhea across developing pharmaceutical landscapes. Our partner facilities are WHO-GMP certified, employing high-precision compression processes that ensure structural stability and reliable active dispersion.